| BE0332-50MG
| InVivoMAb anti-mouse FGL-1
| 50 mg
| BioXCell
| in vivo FGL-1 blockade, in vitro FGL-1 blockade, F
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0364-25MG
| InVivoMAb anti-mouse BTLA (CD272)
| 25 mg
| BioXCell
| in vivo BTLA blockade, Flow cytometry
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0377-50MG
| InVivoMAb anti-mouse CD31 (PECAM-1)
| 50 mg
| BioXCell
| in vivo CD31 blocking, Intravital imaging, Immunof
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0318-100MG
| InVivoMAb anti-human Ganglioside GD2
| 100 mg
| BioXCell
| in vitro induction of apoptosis in GD2+ cells, in
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0371-25MG
| InVivoMAb anti-mouse IL-12 p35
| 25 mg
| BioXCell
| in vivo IL-12 p35 neutralization, in vitro IL-12 p
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0336-25MG
| InVivoMAb anti-human MUC1 (CD227)
| 25 mg
| BioXCell
| in vivo administration in mouse xenograft models,
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0342-5MG
| InVivoMAb recombinant Flt-3L-Ig (hum/hum)
| 5 mg
| BioXCell
|
|
|
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0326-25MG
| InVivoMAb anti-mouse IL-27 p28
| 25 mg
| BioXCell
| in vivo IL-27 p28 neutralization, in vitro IL-27 p
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0299-25MG
| InVivoMAb anti-mouse CD200 (OX2)
| 25 mg
| BioXCell
| in vivo CD200 blockade, in vitro CD200 blockade, I
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0328-25MG
| InVivoMAb anti-mouse CD28
| 25 mg
| BioXCell
| in vivo T cell stimulation/activation, in vitro T
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0350-1MG
| InVivoMAb anti-mouse/human PrP (prion protein)
| 1 mg
| BioXCell
| in vivo PrP blocking, Western blot
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0359-50MG
| InVivoMAb anti-SARS-CoV-2 S protein (RBD epitope B)
| 50 mg
| BioXCell
| in vitro blocking of SARS-CoV-2 S protein, Flow cy
|
| Mouse
| Virus
| Solicitar Precio
| Solicitar
|
| BE0300-50MG
| InVivoMAb anti-mouse CD45.2
| 50 mg
| BioXCell
| Flow cytometry, in vivo CD45.2 blockade, in vitro
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0311-50MG
| InVivoMAb anti-mouse CD317 (BST2, PDCA-1)
| 50 mg
| BioXCell
| in vivo pDC depletion, Immunofluorescence, Flow cy
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0326-1MG
| InVivoMAb anti-mouse IL-27 p28
| 1 mg
| BioXCell
| in vivo IL-27 p28 neutralization, in vitro IL-27 p
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0343-1MG
| InVivoMAb anti-human CD71 (TfR)
| 1 mg
| BioXCell
| Western blot, Immunoprecipitation, Flow cytometry
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0341-1MG
| InVivoMAb anti-human EphA2
| 1 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunoprecipitati
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0376-50MG
| InVivoMAb anti-human CD71 (TfR1)
| 50 mg
| BioXCell
| Flow cytometry*, Immunoprecipitation*, Western blo
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0297-25MG
| InVivoMAb human IgG1 isotype control
| 25 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
| BE0356-1MG
| InVivoMAb anti-mouse CD20
| 1 mg
| BioXCell
| in vivo B cell depletion, Western blot
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0348-100MG
| InVivoMAb anti-mouse CD27
| 100 mg
| BioXCell
| in vivo CD27 stimulation, in vitro CD27 stimulatio
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0358-25MG
| InVivoMAb anti-SARS-CoV-2 S protein (NTD)
| 25 mg
| BioXCell
| Flow cytometry, ELISA
|
| Mouse
| Virus
| Solicitar Precio
| Solicitar
|
| BE0369-5MG
| InVivoMAb polyclonal llama IgG
| 5 mg
| BioXCell
|
|
| Llama
|
| Solicitar Precio
| Solicitar
|
| BE0315-100MG
| InVivoMAb anti-mouse IL-15
| 100 mg
| BioXCell
| in vivo IL-15 neutralization, in vitro IL-15 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0370-50MG
| InVivoMAb anti-human CD71 (TfR1)
| 50 mg
| BioXCell
| Flow cytometry, Immunoprecipitation
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0305-1MG
| InVivoMAb anti-mouse CLEC9A (CD370)
| 1 mg
| BioXCell
| in vivo CLEC9A blockade, in vivo Ag targeting to C
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0334-100MG
| InVivoMAb anti-mouse NKG2D (CD314)
| 100 mg
| BioXCell
| in vivo NKG2D blockade, in vitro NKG2D blockade, F
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0378-1MG
| InVivoMAb anti-mouse CD16.2 (Fc?RIV)
| 1 mg
| BioXCell
| in vivo CD16.2 blockade, in vitro CD16.2 blockade,
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0343-50MG
| InVivoMAb anti-human CD71 (TfR)
| 50 mg
| BioXCell
| Western blot, Immunoprecipitation, Flow cytometry
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0362-1MG
| InVivoMAb anti-human CEACAM 1/3/5/6/8
| 1 mg
| BioXCell
| Western blot, ELISA, Immunofluorescence, Immunohis
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0342-1MG
| InVivoMAb recombinant Flt-3L-Ig (hum/hum)
| 1 mg
| BioXCell
|
|
|
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0312-5MG
| InVivoMAb anti-mouse IFN?
| 5 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0316-5MG
| InVivoMAb anti-mouse CCR3 (CD193)
| 5 mg
| BioXCell
| in vivo eosinophil depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0378-100MG
| InVivoMAb anti-mouse CD16.2 (Fc?RIV)
| 100 mg
| BioXCell
| in vivo CD16.2 blockade, in vitro CD16.2 blockade,
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0339-50MG
| InVivoMAb anti-mouse NKG2AB6
| 50 mg
| BioXCell
| Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0344-5MG
| InVivoMAb anti-mouse TIM-4
| 5 mg
| BioXCell
| Flow cytometry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0348-25MG
| InVivoMAb anti-mouse CD27
| 25 mg
| BioXCell
| in vivo CD27 stimulation, in vitro CD27 stimulatio
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0376-1MG
| InVivoMAb anti-human CD71 (TfR1)
| 1 mg
| BioXCell
| Flow cytometry*, Immunoprecipitation*, Western blo
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0346-5MG
| InVivoMAb anti-mouse CD326 (EpCAM)
| 5 mg
| BioXCell
| Immunohistochemistry (frozen), Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0343-5MG
| InVivoMAb anti-human CD71 (TfR)
| 5 mg
| BioXCell
| Western blot, Immunoprecipitation, Flow cytometry
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0372-50MG
| InVivoMAb anti-mouse osteopontin (SPP1)
| 50 mg
| BioXCell
| in vivo OPN neutralization, in vitro OPN neutraliz
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0314-50MG
| InVivoMAb anti-mouse TIM-1 (CD365)
| 50 mg
| BioXCell
| in vivo TIM-1 blockade, in vitro TIM-1 blockade
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0360-1MG
| InVivoMAb anti-mouse CD24
| 1 mg
| BioXCell
| in vivo administration, Immunohistochemistry (froz
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0344-100MG
| InVivoMAb anti-mouse TIM-4
| 100 mg
| BioXCell
| Flow cytometry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0304-100MG
| InVivoMAb anti-mouse BTLA (CD272)
| 100 mg
| BioXCell
| in vivo BTLA+ B cell and CD4 T cell depletion*, Fl
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0299-100MG
| InVivoMAb anti-mouse CD200 (OX2)
| 100 mg
| BioXCell
| in vivo CD200 blockade, in vitro CD200 blockade, I
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0338-50MG
| InVivoMAb anti-human CD220 (Insulin Receptor)
| 50 mg
| BioXCell
| Western blot
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0361-100MG
| InVivoMAb anti-mouse PD-L1 (B7-H1)
| 100 mg
| BioXCell
| in vivo blocking of PD-L1/CD80 (B7-1) interactions
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0325-5MG
| InVivoMAb anti-West Nile/dengue virus E protein
| 5 mg
| BioXCell
| Neutralization of WNV, Neutralization of DENV1,2,3
|
| Mouse
| Virus
| Solicitar Precio
| Solicitar
|
| BE0305-50MG
| InVivoMAb anti-mouse CLEC9A (CD370)
| 50 mg
| BioXCell
| in vivo CLEC9A blockade, in vivo Ag targeting to C
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|